Mumps virus strain B level jeryl lynn live antigen

DB10316ApprovedInvestigationalVaccinesLive Mumps Virus Vaccine

Mumps virus strain B level jeryl lynn live antigen is a vaccine used to prevent Mumps. It is an active immunization against mumps, which is a common childhood disease.

Primary indication: Mumps virus vaccine is used to prevent mumps in combination with other virus vaccines, such as the rubella and measles virus vaccine.Curator reviewed · 1 structured indication
First approval: Canada, 2001 · United States, 1971 · European Union, 2021
Also known as: Mumps virus vaccine live attenuated (Jeryl Lynn strain) · Mumps Virus Vaccine Live, Jeryl Lynn Strain
Brand names: M-M-R II
M-M-RVaxPro
Proquad

Resolves to

Compound

UNII47QB6MX9KU

Clinical / RWD

RxNorm798372

What you can answer from here — as of May 03, 2025

290Drug interactionsStructured to mechanism, not free text

92Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

3ContraindicationsEach with its own population and attribute set

131Marketed productsAcross 9 countries and 16 labellers

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Mumps virus strain B level jeryl lynn live antigen, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account